SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-24-015061
Filing Date
2024-02-16
Accepted
2024-02-16 21:51:13
Documents
1
Period of Report
2023-11-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 3/A  
1 ownership.xml 3/A 4142
  Complete submission text file 0001213900-24-015061.txt   5826
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Issuer) CIK: 0001840563 (see all company filings)

IRS No.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 650 WEST GEORGIA STREET #3200 VANCOUVER Z4 V6B 4P7
Business Address 650 WEST GEORGIA STREET #3200 VANCOUVER Z4 V6B 4P7 866-794-4940
BWL Investments Ltd. (Reporting) CIK: 0002003791 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-41875 | Film No.: 24650421